Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Carbetocin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 4 (2)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04595812Phase 4UnknownPrimary

Methods to Reduce Blood Loss in Abdominal Myomectomy

NCT04083625Phase 4CompletedPrimary

the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

Showing all 2 trials

Research Network

Common Treatments

  • Carbetocin2
  • Misoprostol1
  • Oxytocin1
  • Pericervical Hemostatic Tourniquet1

Active Sponsors

  • Cairo University2

Top Investigators

Related Conditions

  • Blood Loss1

Activity Timeline